CliniGenetics is a biopharmaceutical company devoted to the discovery and development of new molecules for the treatment of complex metabolic diseases and their cardiovascular complications. These diseases are the main cause of morbidity and death in the developed world. The goal of the company is to develop its portfolio of new therapeutic small molecules to block the growth and the vulnerability of atheroscerotic plaques and for the treatment of metabolic syndroms associated with heart failure and heart ischemia.
Looking for a particular CliniGenetics SA employee's phone or email?
The CliniGenetics SA annual revenue was $3.6 million in 2026.
CliniGenetics SA is based in Nimes, Occitania.
The NAICS codes for CliniGenetics SA are [32541, 33, 32, 336, 3254, 325].
The SIC codes for CliniGenetics SA are [283, 28, 2834, 374, 37].